« IVF technique enables pregnancy without multiple births, Stanford researchers find | Main | Orange County’s “Physicians Of Excellence” Award »

Collaborative PGD Study by Drs. Werlin and Munné Et. Al to Be Presented At American Society of Reproductive Medicine Conference

I am very excited to tell you that a colleague of mine, internationally-recognized fertility researcher Dr. Santiago Munné, is presenting our collaborative study at the upcoming American Society of Reproductive Medicine (ASRM) Annual Conference. The study presents groundbreaking discoveries on the impact of Preimplantation Genetic Diagnosis (PGD) on live birth rates for women of advanced maternal age. The conference, held in Washington, D.C., is an assembly of leaders in the field of reproductive medicine from throughout North America and abroad.

Our study includes data which suggests that PGD can significantly increase the chance of pregnancy to term in multiple In Vitro Fertilization (IVF) programs, while also reducing the risk of miscarriage in women ages 38 to 42. Results also indicate that PGD is more effective in some IVF centers compared to others, which suggests that patient selection, follicular stimulation, culture system and biopsy may play important roles.

This study gives new hope to women of advanced maternal age who want to begin a family. PGD reduces the chance for spontaneous miscarriage and increases take-home baby rates.

PGD is a therapeutic, genetic testing tool that allows for the analysis and transfer of healthy embryos back into the uterus. The procedure has gained recognition for its ability to analyze the cells of a developing embryo via biopsy for genetic and chromosomal abnormalities.

The study included results from fertility clinics across the United States including Reprogenetics and the Institute for Reproductive Medicine and Science at Saint Barnabas, both in N.J.; Zouves Fertility Center, Coastal Fertility Medical Center, and The Center for Reproductive Medicine, located in Calif.; and Highland Park IVF Laboratory in Ill. Munné will present the study to attendees at the ASRM Conference on Wednesday, Oct. 17.

About Dr. Munné
Dr. Santiago Munné, an award-winning and internationally recognized leader in reproductive medicine research, is the director of Preimplantation Genetic Diagnosis at Reprogenetics, LLC. He is a member of the American Society for Reproductive Medicine and the American Society of Human Genetics and Alpha, an international organization for scientists in reproductive medicine. For more information, visit http://www.Reprogenetics.com.

About The American Society of Reproductive Medicine
The American Society for Reproductive Medicine, founded in 1944, is an organization of more than 8,000 physicians, researchers, nurses, technicians, and other professionals dedicated to advancing knowledge and expertise in reproductive biology. Affiliated societies include the Society for Assisted Reproductive Technology, the Society for Male Reproduction and Urology, the Society for Reproductive Endocrinology and Infertility, and the Society of Reproductive Surgeons. To learn more about the Annual ASRM Conference, please visit http://www.ASRM.org.

TrackBack

TrackBack URL for this entry:
http://www.werlsfertilityworld.com/cgi-bin/mt/mt-tb.cgi/228

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

About

This page contains a single entry from the blog posted on October 8, 2007 5:33 PM.

The previous post in this blog was IVF technique enables pregnancy without multiple births, Stanford researchers find.

The next post in this blog is Orange County’s “Physicians Of Excellence” Award.

Many more can be found on the main index page or by looking through the archives.

Powered by
Movable Type Pro